Target intelligence / Profile preview

Metabolic ammonia handling pathways

Molecular classification
Enzyme, Transporter
01

Overview

Metabolic ammonia handling pathways represent the collective biochemical systems responsible for the detoxification and excretion of ammonia, a neurotoxic byproduct of protein metabolism. The central component is the urea cycle, a series of five enzymatic reactions in the liver—including carbamoyl phosphate synthetase I and ornithine transcarbamylase—that convert ammonia into water-soluble urea for renal excretion (StatPearls, 2023). Secondary pathways involve the synthesis of glutamine by glutamine synthetase in the brain, muscle, and liver, as well as the transport of ammonia across cell membranes via Rh glycoproteins (PubMed, 2018). Impairment of these pathways, whether due to genetic defects (urea cycle disorders) or acquired liver disease (cirrhosis), leads to hyperammonemia, which can cause life-threatening cerebral edema and hepatic encephalopathy (NIH, 2022). Therapeutic strategies focus on reducing the ammonia load through nitrogen-scavenging agents that provide alternative excretion routes or by using antibiotics and osmotic laxatives to decrease ammonia production in the gastrointestinal tract (Journal of Hepatology, 2019).

Other names
Urea cycleAmmonia detoxification pathwaysNitrogen metabolismAmmonia homeostasisUreagenesis
02

Mechanism of action

Drugs targeting these pathways function by scavenging excess nitrogen through alternative metabolic routes (e.g., phenylbutyrate forming phenylacetylglutamine), reducing ammonia production by enteric bacteria (e.g., rifaximin, lactulose), or providing essential intermediates and enzyme activators to restore urea cycle flux (e.g., carglumic acid, arginine).

03

Biological functions

Nitrogen excretionAmino acid metabolismpH regulationUrea synthesisGlutamine metabolism
04

Disease associations

HyperammonemiaUrea cycle disordersHepatic encephalopathyLiver cirrhosisAcute liver failureInborn errors of metabolism
05

Safety considerations

Electrolyte imbalances (e.g., hypokalemia)Metabolic acidosis or alkalosisGastrointestinal distressSodium overload (from sodium-based scavengers)Potential for neurotoxicity if ammonia levels are not rapidly controlled
06

Interacting drugs

Sodium phenylbutyrate

7 more in the full profile.

07

Biomarkers

Blood ammonia levelPlasma glutamine concentrationPlasma citrulline levelUrinary orotic acidPlasma amino acid profile

Beyond the preview

Go deeper on Metabolic ammonia handling pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Metabolic ammonia handling pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call